Novel radiolabeled ligand, Para-chloro-2-[ 18 F]fluoroethyletomidate (CETO) compared to [ 11 C]metomidate-PET (MTO) for the lateralisation of primary aldosteronism (PA)
Publisher
DOI
10.1530/endoabs.86.op2.1
Journal
Endocrine Abstracts
ISSN
1470-3947